Success Metrics

Clinical Success Rate

84.9%

Based on 377 completed trials

Completion Rate

85%(377/444)

Active Trials

74(11%)

Results Posted

47%(176 trials)

Terminated

67(10%)

Phase Distribution

Ph not_applicable

146

22%

Ph phase_2

131

19%

Ph phase_4

190

28%

Ph early_phase_1

Ph phase_3

Ph phase_1

13%

Phase Distribution

120

Early Stage

131

Mid Stage

248

Late Stage

Phase Distribution645 total trials

Early Phase 1First-in-human

32(5.0%)

Phase 1Safety & dosage

88(13.6%)

Phase 2Efficacy & side effects

131(20.3%)

Phase 3Large-scale testing

58(9.0%)

Phase 4Post-market surveillance

190(29.5%)

N/ANon-phased studies

146(22.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.9%

377 of 484 finished

Non-Completion Rate

22.1%

107 ended early

Currently Active

trials recruiting

Total Trials

678

all time

Status Distribution

Active(93)

Completed(377)

Terminated(107)

Other(101)

Detailed Status

Completed377

unknown93

Terminated67

Recruiting61

Withdrawn40

Not yet recruiting16

Development Timeline

Analytics

Development Status

Total Trials

678

Active

Success Rate

84.9%

Most Advanced

Phase 4

Trials by Phase

Early Phase 132 (5.0%)

Phase 188 (13.6%)

Phase 2131 (20.3%)

Phase 358 (9.0%)

Phase 4190 (29.5%)

N/A146 (22.6%)

Trials by Status

enrolling_by_invitation30%

completed37756%

unknown9314%

suspended81%

terminated6710%

not_yet_recruiting162%

recruiting619%

withdrawn406%

active_not_recruiting132%

Recent Activity

74 active trials

Showing 5 of 678

recruitingearly_phase_1

Ketamine and Propofol NeuroImaging

NCT07294092

recruitingphase_1

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

NCT06085937

active_not_recruitingphase_2

Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

NCT06538285

completednot_applicable

Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

NCT07526454

recruitingphase_2

Ketamine for Veterans With Parkinson's Disease

NCT06231563

View all 678 trials

Clinical Trials (678)

Showing 20 of 678 trialsScroll for more

NCT07294092Early Phase 1

Ketamine and Propofol NeuroImaging

Recruiting

NCT06085937Phase 1

Feasibility and Safety of Ketamine for Suicidal Patients in the Emergency Department

Recruiting

NCT06538285Phase 2

Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV

Active Not Recruiting

NCT07526454Not Applicable

Electroconvulsive Therapy Versus Intravenous Ketamine in Treatment-Resistant Major Depressive Disorder

Completed

NCT06231563Phase 2

Ketamine for Veterans With Parkinson's Disease

Recruiting

NCT05401227Phase 1

Glutamatergic Mechanisms: Aim2

Suspended

NCT05518877Phase 4

Low Dose Ketamine Infusion for Analgesia in the Emergency Department to Reduce Side Effects

Completed

NCT04248205Phase 4

Ketamine for Post-operative Analgesia in Hemorrhoidectomy

Recruiting

NCT05505630Early Phase 1

The Effects of Sedatives on Tobacco Use Disorder Version 2

Completed

NCT07066306Not Applicable

Effects of Local Ketamine in Orthognathic Procedures

Active Not Recruiting

NCT06867068Phase 1

Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery

Completed

NCT04751175Phase 4

Management of Pain in Lumbar Arthrodesis

Completed

NCT06378528Early Phase 1

Ketamine-assisted Psychotherapy for Adolescent PTSD (KAP)

Suspended

NCT05277896Phase 4

Randomized Trial of Sedative Choice for Intubation

Completed

NCT07001605Not Applicable

Erector Spinae Block Vs Ketamine-based Multimodal Analgesia Protocol in Lumber Decompressive Surgery

Completed

NCT06903819Phase 4

Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients

Recruiting

NCT06480201Phase 1

Gamma Oscillations as a Prognostic Marker for Ketamine Therapy in Treatment Resistant Depression

Suspended

NCT05378100Phase 2

Ketamine for Multiple Sclerosis Fatigue

Active Not Recruiting

NCT06781697Phase 3

InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression

Not Yet Recruiting

NCT07443254Phase 1

Prospective IR-led Sedation Feasibility

Recruiting

Drug Details

Intervention Type: DRUG
Total Trials: 678